Abstract
Background/objectives
Overweight and obesity drive cardiometabolic disease and high-intensity lifestyle interventions are standard. However, many health-systems cannot offer these interventions and many patients cannot participate even when available. Trials have assessed automated digital lifestyle interventions to improve accessibility. This systematic review identified automated digital lifestyle interventions and assessed their impact on weight loss.
Subjects/methods
The review (CRD42023435700) identified randomized controlled trials of at least 3-months duration assessing automated digital lifestyle interventions’ impact on weight loss. Data were managed through Covidence with double-blinded screening of titles/abstracts and double-blinded full-text review to determine study inclusion. Data extraction was completed by one reviewer (NWC) and verified by a second (MM, JS, TE, CE). The Cochrane Collaboration’s tool was used to assess bias risk and study quality was rated as High, Moderate, Low, or Very Low.
Results
The search identified 1817 citations. The full-text of 60 reports were assessed and 17 reports of 16 studies were included. The majority (63%) were of moderate quality. No intervention produced 5% weight loss from baseline. Intervention components with the largest impact were text message encouragement and education with a cognitive behavioral approach. No specific form of self-monitoring was most effective, though some form of self-monitoring was included in most trials.
Conclusions
Some components of the automated digital lifestyle interventions showed promise. Research is needed to optimize these components (e.g., tailored messaging, cognitive-behavioral approaches) balanced with human contact. Considering the magnitude of the problem and its disproportionate impact on low socioeconomic and minority patients, interventions optimized for effect and scalability are needed to address overweight and obesity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
References
Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2024 Heart Disease and Stroke Statistics: a report of US and global data from the American Heart Association. Circulation 2024;149:e347–e913.
American Diabetes Association Professional Practice Committee. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes-2024. Diabetes Care. 2024;47:S145–57.
Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129:S102–38.
Ely EK, Gruss SM, Luman ET, Gregg EW, Ali MK, Nhim K, et al. A national effort to prevent type 2 diabetes: participant-level evaluation of CDC’s national diabetes prevention program. Diabetes Care. 2017;40:1331–41.
Porter J, Boyd C, Skandari MR, Laiteerapong N. Revisiting the time needed to provide adult primary care. J Gen Intern Med. 2023;38:147–55.
Marcolino MS, Oliveira JAQ, D’Agostino M, Ribeiro AL, Alkmim MBM, Novillo-Ortiz D. The impact of mHealth interventions: systematic review of systematic reviews. JMIR Mhealth Uhealth. 2018;6:e23.
Curry D. MyFitnessPal Revenue and Usage Statistics (2024). Business of Apps. Available at: https://www.businessofapps.com/data/myfitnesspal-statistics/. Accessed 22 April 2024.
Carris N, Bullers K, Eubanks T, Epperson C, McKee M, Sempek J, et al. The impact of automated lifestyle interventions on health outcomes: a systematic review of randomized controlled trials. PROSPERO 2023 CRD42023435700 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023435700. Accessed 22 April 2024.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clin Res ed). 2021;372:n71.
McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40–6.
Glanville J, Foxlee R, Wisniewski S, Noel-Storr A, Edwards M, Dooley G. Translating the Cochrane EMBASE RCT filter from the Ovid interface to Embase.com: a case study. Health Info Libr J. 2019;36:264–77.
Covidence. Systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Clin Res ed). 2011;343:d5928.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clin Res ed). 2008;336:924–6.
Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401–6.
Baer HJ, Rozenblum R, De La Cruz BA, Orav EJ, Wien M, Nolido NV, et al. Effect of an online weight management program integrated with population health management on weight change: a randomized clinical trial. JAMA. 2020;324:1737–46.
Bootwong P, Intarut N. The effects of text messages for promoting physical activities in prediabetes: a randomized controlled trial. Telemed J E Health. 2022;28:896–903.
Glasgow RE, Kurz D, King D, Dickman JM, Faber AJ, Halterman E, et al. Twelve-month outcomes of an Internet-based diabetes self-management support program. Patient Educ Couns. 2012;87:81–92.
Gomez-Marcos MA, Patino-Alonso MC, Recio-Rodriguez JI, Agudo-Conde C, Romaguera-Bosch M, Magdalena-Gonzalez O, et al. Short- and long-term effectiveness of a smartphone application for improving measures of adiposity: a randomised clinical trial - EVIDENT II study. Eur J Cardiovasc Nurs. 2018;17:552–62.
Greene J, Sacks R, Piniewski B, Kil D, Hahn JS. The impact of an online social network with wireless monitoring devices on physical activity and weight loss. J Prim Care Community Health. 2013;4:189–94.
Hajna S, Sharp SJ, Cooper AJM, Williams KM, van Sluijs EMF, Brage S, et al. Effectiveness of minimal contact interventions: an RCT. Am J Prev Med. 2021;60:e111–e21.
Hoerster KD, Hunter-Merrill R, Nguyen T, Rise P, Barón AE, McDowell J, et al. Effect of a remotely delivered self-directed behavioral intervention on body weight and physical health status among adults with obesity: the D-ELITE randomized clinical trial. JAMA. 2022;328:2230–41.
King AC, Campero MI, Sheats JL, Castro Sweet CM, Hauser ME, Garcia D, et al. Effects of counseling by peer human advisors vs computers to increase walking in underserved populations: the COMPASS randomized clinical trial. JAMA Intern Med. 2020;180:1481–90.
Laing BY, Mangione CM, Tseng CH, Leng M, Vaisberg E, Mahida M, et al. Effectiveness of a smartphone application for weight loss compared with usual care in overweight primary care patients: a randomized, controlled trial. Ann Intern Med. 2014;161:S5–12.
Lugones-Sanchez C, Recio-Rodriguez JI, Agudo-Conde C, Repiso-Gento I, G Adalia E, Ramirez-Manent JI, et al. Long-term effectiveness of a smartphone app combined with a smart band on weight loss, physical activity, and caloric intake in a population with overweight and obesity (evident 3 study): randomized controlled trial. J Med Internet Res. 2022;24:e30416.
Lugones-Sanchez C, Sanchez-Calavera MA, Repiso-Gento I, Adalia EG, Ramirez-Manent JI, Agudo-Conde C, et al. Effectiveness of an mHealth intervention combining a smartphone app and smart band on body composition in an overweight and obese population: randomized controlled trial (EVIDENT 3 Study). JMIR Mhealth Uhealth. 2020;8:e21771.
Mensorio MS, Cebolla-Martà A, Rodilla E, Palomar G, Lisón JF, Botella C, et al. Analysis of the efficacy of an internet-based self-administered intervention (“Living Better”) to promote healthy habits in a population with obesity and hypertension: an exploratory randomized controlled trial. Int J Med Inf. 2019;124:13–23.
Shaw RJ, Bosworth HB, Silva SS, Lipkus IM, Davis LL, Sha RS, et al. Mobile health messages help sustain recent weight loss. Am J Med. 2013;126:1002–9.
Silina V, Tessma MK, Senkane S, Krievina G, Bahs G. Text messaging (SMS) as a tool to facilitate weight loss and prevent metabolic deterioration in clinically healthy overweight and obese subjects: a randomised controlled trial. Scand J Prim Health Care. 2017;35:262–70.
Tate DF, Kraschnewski JL, Martinez C, Diamond M, Veldheer S, Hwang KO, et al. A cluster-randomized controlled trial of automated internet weight-loss programs in primary care: role of automated provider feedback. Obesity. 2022;30:2363–75.
Jahangiry L, Shojaeizadeh D, Abbasalizad Farhangi M, Yaseri M, Mohammad K, Najafi M, et al. Interactive web-based lifestyle intervention and metabolic syndrome: findings from the Red Ruby (a randomized controlled trial). Trials. 2015;16:418.
Peimani M, Rambod C, Omidvar M, Larijani B, Ghodssi-Ghassemabadi R, Tootee A, et al. Effectiveness of short message service-based intervention (SMS) on self-care in type 2 diabetes: a feasibility study. Prim Care Diabetes. 2016;10:251–8.
Oussedik E, Foy CG, Masicampo EJ, Kammrath LK, Anderson RE, Feldman SR. Accountability: a missing construct in models of adherence behavior and in clinical practice. Patient Prefer Adher. 2017;11:1285–94.
Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (Clin Res ed). 2014;348:g1687.
Cowart K, Updike W, Bullers K. Systematic review of randomized controlled trials evaluating glycemic efficacy and patient satisfaction of intermittent-scanned continuous glucose monitoring in patients with diabetes. Diabetes Technol Ther. 2020;22:337–45.
Kelly WN, Ho MJ, Bullers K, Klocksieben F, Kumar A. Association of pharmacist counseling with adherence, 30-day readmission, and mortality: A systematic review and meta-analysis of randomized trials. J Am Pharmacists Assoc. 2021;61:340–50.e5.
Kelly WN, Ho MJ, Smith T, Bullers K, Kumar A. Association of pharmacist intervention counseling with medication adherence and quality of life: a systematic review and meta-analysis of randomized trials. J Am Pharm Assoc. 2023;63:1095–105.
Updike WH, Pane O, Franks R, Saber F, Abdeen F, Balazy DD, et al. Is it time to expand glucagon-like peptide-1 receptor agonist use for weight loss in patients without diabetes? Drugs. 2021;81:881–93.
Carris NW, Taylor JR, Gums JG. Combining a GLP-1 receptor agonist and basal insulin: study evidence and practical considerations. Drugs. 2014;74:2141–52.
Carris NW, Pardo J, Montero J, Shaeer KM. Minocycline as a substitute for doxycycline in targeted scenarios: a systematic review. Open Forum Infect Dis. 2015;2:ofv178.
Patel RV, Shaeer KM, Patel P, Garmaza A, Wiangkham K, Franks RB, et al. EPA-registered repellents for mosquitoes transmitting emerging viral disease. Pharmacotherapy. 2016;36:1272–80.
American Diabetes Association Professional Practice Committee. Diabetes technology: standards of care in diabetes-2024. Diabetes care. 2024;47:S126–44.
Anderson K. Popular fad diets: an evidence-based perspective. Prog Cardiovasc Dis. 2023;77:78–85.
Internet/broadband fact sheet. Pew Research Center: Internet, Science & Technology 2021. Available from: https://www.pewresearch.org/internet/fact-sheet/internet-broadband/. Accessed 23 April 2024.
Mobile fact sheet. Pew Research Center: Internet, Science & Tech. 2021. Available from: https://www.pewresearch.org/internet/fact-sheet/mobile/. Accessed 23 April 2024.
Rodriguez LA, Bradshaw PT, Shiboski SC, Fernandez A, Vittinghoff E, Herrington D, et al. Examining if the relationship between BMI and incident type 2 diabetes among middle-older aged adults varies by race/ethnicity: evidence from the Multi-Ethnic Study of Atherosclerosis (MESA). Diabet Med. 2021;38:e14377.
Author information
Authors and Affiliations
Contributions
Nicholas W. Carris: Conceptualization, Methodology, Investigation, Writing—Original Draft, Writing—Review & Editing, Supervision Krystal Bullers: Methodology, Writing—Original Draft, Writing—Review & Editing Mariam McKee: Investigation, Writing—Review & Editing Jena Sempek: Investigation, Writing—Review & Editing Taylor Eubanks: Investigation, Writing—Review & Editing Christa Epperson: Investigation, Writing—Review & Editing Marilyn Stern: Writing—Review & Editing Brian E. Bunnell: Writing—Review & Editing.
Corresponding authors
Ethics declarations
Competing interests
NWC reports research funding from Sanofi Winthrop Industrie with funds received and managed by the University of South Florida. BEB has equity in Adhere.ly LLC, a health technology company. The remaining authors have nothing to disclose.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Carris, N.W., Bullers, K., McKee, M. et al. Automated lifestyle interventions and weight loss: a systematic review of randomized controlled trials. Int J Obes 49, 992–997 (2025). https://doi.org/10.1038/s41366-025-01746-0
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41366-025-01746-0
This article is cited by
-
Automated lifestyle interventions and weight loss: a systematic review of randomized controlled trials
International Journal of Obesity (2025)


